Abvc Biopharma ABVC
NASDAQ ABVC
$1.01 -0.01 (-0.98%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Price to Earnings (2024 - 2025)

Updated

Abvc Biopharma's Price to Earnings was 10.45 in Q3 2025, up 114.3% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Price to Earnings (2024 - 2025) Analysis & Trends

For FY2024, Price to Earnings at Abvc Biopharma came in at 1.56.

  • Per Business Quant data, ABVC's Price to Earnings in the three quarters before Q3 2025 was 4.88 (Q2 2025), 1.61 (Q1 2025) and 1.31 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Abvc Biopharma 26.03 Mn 28.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 10.45
Jun 30, 2025 4.88
Mar 31, 2025 1.61
Dec 31, 2024 1.31
API Access

Abvc Biopharma Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABVC&period=max&api_key=YOUR_API_KEY